TheEficacyof XingnaoTongshuanPilsinTreatingPatientswithlschemicStrokeofMiddleMetabolismofCYP2C19Geneinthe Recovery Period and Its Impact on Coagulation Function CHENG Hongjie1，LI Yan1，YANG Yongqin1，HUA Xiaokal2， SUN Tiefeng

    1.Xintai HospitalofTraditionalChineseMedicine，Qingdao UniversityMedicalGroup-XinTaiBranchHospital，Taan2Shandong， China;2.TheSecondAfliatedHospitalofShandongUniversityofTraditionalChineseMedicine；3.ShandongAcademyofChinese Medicine

    CorrespondingAuthor Ll Yan，E-mail： lysdzyy00 @ 163.com

    AbstractObjective：Texploretheeficacyof XingnaoTongshuanPilsitreatingpatientswithischemic strokeofmidlemetabismf CYP2C19geneintherecoveryperiodanditsimpactoncoagulationfunctoMetods：Ninetyfourpatientswitischemictrokeofmiddle metabolismofCYP219geneintherecoveryperiod(withphlegm-stasisblockingthemeridianssyndrome)weredividedintothecontrol groupandtheobservationgroupacordingtotherandomnumbertablemethodwith47casesineachgroup.Thecontrolgroupreceived aspirinandclodogreloservationgroupwasgiventeXingnaoongsuanPilsiaditiotottreatmentofteontrolgroupe treatmentlastedforatotalof2eks.TeChiesemedicinesdromescoresterapeuticficacyofsndromeneurologicalfuction [NationalInstiutesofHealtroealeNse]llinbitymidtelidex)ntiplateetiatoel agregationratedenosinediposphate(AinbtionateoodclotsiA)moreologicalidicator(wolebloodr viscosityholeloarsityasosityndauatiodicatosactiatedrtalombopsti prothrombintime(PDdimerD-D)levelbeforeandaftertreatmentinthetgroupsResults：etotaefectiverateofCsdome inthe observation group was higher than that in the control group 95.74% VS 78.72% 5 Plt;0.05 ).Aftertreatment ......